Cargando…

A Study of the Peripheral Vessels in Patients With Type 2 Diabetes Mellitus With or Without Foot Involvement

Peripheral vascular disease (PVD) is chronic limb ischemia caused by atherosclerosis of the peripheral arteries. Diabetes mellitus (DM) is a risk factor for this disease. The probability of a diabetic foot ulcer (DFU) is higher in a patient with DM and PVD than in a patient without DM. Ankle-brachia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Das, Pragateshnu, Bhattacharya, Debmalya, Sathpathy, Rajlaxmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518815/ https://www.ncbi.nlm.nih.gov/pubmed/36185939 http://dx.doi.org/10.7759/cureus.28542

Ejemplares similares

Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus
por: Chauhan, Sukhjinder, et al.
Publicado: (2023)

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Therapy for the Primary and Secondary Prevention of Heart Failure in Patients With and Without Type 2 Diabetes Mellitus: A Systematic Review
por: Wahinya, Maureen, et al.
Publicado: (2023)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus
por: Younas, Amna, et al.
Publicado: (2021)

A Review on Glycemic Control in Type 2 Diabetes Mellitus by Arm Ergometer Exercise
por: Dhait, Shubhada R, et al.
Publicado: (2022)

Risk Factors of Peripheral Vascular Disease in Diabetes Mellitus in Abbottabad, Pakistan: A Cross-Sectional Study
por: Majid Khan, Abdul, et al.
Publicado: (2021)

A Patient Loses 18 kg and Type 2 Diabetes Mellitus: The Challenge of Complete Remission
por: Odhaib, Samih A, et al.
Publicado: (2019)

Associations Between Bioavailable Vitamin D and Remnant Cholesterol in Patients With Type 2 Diabetes Mellitus
por: Turkes, Gulsum Feyza, et al.
Publicado: (2021)

Comparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia
por: Aleem, Mudassar, et al.
Publicado: (2022)

Resistant Hypertension in Patients With Type-2 Diabetes Mellitus: A Single-Center, Cross-Sectional Study
por: Binaqeel, Aqeel S, et al.
Publicado: (2022)

Effects of Sodium-Glucose Cotransporter Inhibitor Use in Type 2 Diabetes Mellitus Patients With Heart Failure
por: Choday, Silpa, et al.
Publicado: (2023)

Evidence-Based Clinical Review on Cardiovascular Benefits of SGLT2 (Sodium-Glucose Co-Transporter Type 2) Inhibitors in Type 2 Diabetes Mellitus
por: Rehman, Saad U, et al.
Publicado: (2020)

Lipoprotein Ratios: A Potential Biomarker for Clinical Diagnosis of Atherosclerosis in Type 1 Diabetic Patients With Foot Ulceration
por: Hamri, Walid Hassene, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 and Its Association With Oxidative Stress and Lipid Profile in Type 2 Diabetes Mellitus
por: Aleem, Mudassar, et al.
Publicado: (2021)

A Cross-Sectional Study to Determine the Association of Corrected QT Interval With Microalbuminuria in Type 2 Diabetes Mellitus
por: Sawarthia, Sonali, et al.
Publicado: (2023)

Target Vessel Versus Complete Revascularization in Non-ST Elevation Myocardial Infarction Without Cardiogenic Shock
por: Pandit, Neeraj, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors: Delving Into the Potential Benefits of Cardiorenal Protection Beyond the Treatment of Type-2 Diabetes Mellitus
por: Srinivas, Natasha, et al.
Publicado: (2021)

Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review
por: Sarker, Aditi, et al.
Publicado: (2022)

Do SGLT2 Inhibitors Improve Cardio-Renal Outcomes in Patients With Type II Diabetes Mellitus: A Systematic Review
por: Kalluri, Sahithi Reddy, et al.
Publicado: (2021)

Prevalence of Cardiovascular Risk Factors Among Patients With Diabetes Mellitus Type 2 at King Fahad University Hospital, Saudi Arabia
por: Jatoi, Noor-Ahmed, et al.
Publicado: (2022)

Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein
por: Juhi, Ayesha, et al.
Publicado: (2023)

The Association Between Microalbuminuria and QTc Prolongation in Patients With Type 2 Diabetes Mellitus: A Single-Centre Study From South India
por: Dominic, Solomon K, et al.
Publicado: (2023)

Development of Multi-Vessel Coronary No-Reflow Following Elective Percutaneous Intervention in One Vessel
por: Hussain, Syed W, et al.
Publicado: (2023)

Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study
por: Cheng, Po Chung, et al.
Publicado: (2017)

A Systematic Review and Meta-Analysis on the Efficacy and Safety of Finerenone Therapy in Patients with Cardiovascular and Chronic Kidney Diseases in Type 2 Diabetes Mellitus
por: Jyotsna, FNU, et al.
Publicado: (2023)

Kinetics and kinematics of diabetic foot in type 2 diabetes mellitus with and without peripheral neuropathy: a systematic review and meta-analysis
por: Hazari, Animesh, et al.
Publicado: (2016)

Readiness of the primary health care units and associated factors for the management of hypertension and type II diabetes mellitus in Sidama, Ethiopia
por: Mulugeta, Tigist Kebede, et al.
Publicado: (2022)

Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus: A Single-Centre Observational Study From a Tertiary Care Hospital in South India
por: CM, Wazeem, et al.
Publicado: (2023)

Exercise based assessment of cardiac autonomic function in type 1 versus type 2 diabetes mellitus
por: Goldberger, Jeffrey J., et al.
Publicado: (2022)

Multi-Vessel Coronary Artery Ectasia
por: Madkour, Muhammad, et al.
Publicado: (2021)

Assessment of the Safety, Efficacy, and Benefit of Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Heart Failure With Reduced Ejection Fraction (HFrEF) at High Risk for Cardiovascular Events
por: Towiargi, Ruba, et al.
Publicado: (2022)

Diabetes Mellitus and Cardiomyopathy as Presenting Features of Occult Malignant Pheochromocytoma
por: Inthaphan, Piti, et al.
Publicado: (2021)

Outcomes of Hospitalized Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) With and Without a History of Peripheral Artery Disease
por: Khrais, Ayham, et al.
Publicado: (2022)

Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus
por: Ali, Azka, et al.
Publicado: (2021)

Obesity, Diabetes Mellitus, and Vascular Impediment as Consequences of Excess Processed Food Consumption
por: Sinha, Susmita, et al.
Publicado: (2022)

Peripheral Neuropathy as a Risk Factor for Developing Cardiovascular Disease in Diabetic Patients
por: AlGhamdi, Ghassan, et al.
Publicado: (2020)

Role of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction: A Review Article
por: Mgbemena, Okechukwu, et al.
Publicado: (2021)

Fatal Multi-Vessel Coronary Vasospasm: A Case Report
por: Aissaoui, Hanane, et al.
Publicado: (2020)

Quantifying Remission Probability in Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2021)

Peripheral retinal vessel whitening in patients with diabetes mellitus
por: Kalaw, Fritz Gerald P., et al.
Publicado: (2023)

Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients
por: Peela, Jagannadha R, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kne4t6kmcdc2cfali5m745ap6d